Respiratory diseases like asthma, COPD, and lung cancer are becoming more common over the world. COPD affects roughly 65 million people worldwide, according to the World Health Organization. COPD is also on the rise in terms of prevalence, with three million fatalities in 2015, accounting for 5% of all global deaths. This opens up a lot of doors for interventional pulmonology in different parts of the world. The demand for shorter recovery times and less discomfort during procedures and surgeries for respiratory illnesses has bolstered the Interventional Pulmonology Market.
The acquisition of local players by leading interventional pulmonology providers is focusing on geographical expansion in emerging countries. Some companies are focusing on working with diagnostic centers and hospitals for direct equipment sales and maintenance, as well as personnel training to raise awareness of new technologies. Furthermore, rising healthcare spending in emerging nations and better reimbursement policies are driving new interventional pulmonology device manufacturers to enter the market, with the United States and Europe projected to offer the biggest chances.
Read @ https://cmilatestinsights.blogspot.com/2021/12/global-interventional-pulmonology.html
